Mednet Logo
HomeGynecologic OncologyQuestion

When do you refer a patient with metastatic ovarian cancer for upfront debulking v. neoadjuvant chemotherapy?

1
1 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · USC Keck School of Medicine

In general, I would advise referring the patient to a gynecologic oncologist prior to chemotherapy as the decision regarding upfront versus interval debulking is complicated and best made assessing the patient and her imaging in person. However, if it is not possible to get the patient referred in a...

Register or Sign In to see full answer

When do you refer a patient with metastatic ovarian cancer for upfront debulking v. neoadjuvant chemotherapy? | Mednet